![Jack J. Kogut](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jack J. Kogut
Keine laufenden Positionen mehr
Karriereverlauf von Jack J. Kogut
Ehemalige bekannte Positionen von Jack J. Kogut
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Northfield Laboratories, Inc.
![]() Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Verwaltungsdirektor | 01.01.1994 | 08.05.2009 |
Finanzdirektor/CFO | 01.01.1994 | 08.05.2009 | |
Unternehmenssekretär | 01.01.1994 | 08.05.2009 | |
Treasurer | 01.01.1994 | 08.05.2009 | |
Apogent Technologies, Inc.
![]() Apogent Technologies, Inc. Medical SpecialtiesHealth Technology Apogent Technologies, Inc. used to design and manufacture laboratory equipment. It was also developer and manufacturer of value-added products for the clinical and research markets. Apogent's operating subsidiaries were manufactures most of their products in approximately 80 facilities worldwide. It sells its goods primarily through distributors, but also directly to end users in the industrial, clinical and research markets. The company was located in Portsmouth, NH. | Corporate Officer/Principal | 01.01.1982 | 01.01.1986 |
Sybron Asia (HK) Ltd. | Präsident | 01.01.1982 | 01.01.1986 |
Ausbildung von Jack J. Kogut
Loyola University of Chicago | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 4 |
Hong Kong | 2 |
Operativ
Chief Administrative Officer | 1 |
Director of Finance/CFO | 1 |
Corporate Secretary | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Northfield Laboratories, Inc.
![]() Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Health Technology |
Apogent Technologies, Inc.
![]() Apogent Technologies, Inc. Medical SpecialtiesHealth Technology Apogent Technologies, Inc. used to design and manufacture laboratory equipment. It was also developer and manufacturer of value-added products for the clinical and research markets. Apogent's operating subsidiaries were manufactures most of their products in approximately 80 facilities worldwide. It sells its goods primarily through distributors, but also directly to end users in the industrial, clinical and research markets. The company was located in Portsmouth, NH. | Health Technology |
Sybron Asia (HK) Ltd. |
- Börse
- Insiders
- Jack J. Kogut
- Erfahrung